Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_status_consensus
HSPG2	3339	broad.mit.edu	37	1	22202372	22202372	+	Missense_Mutation	SNP	A	A	G			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr1:22202372A>G	ENST00000374695.3	-	24	3246	c.3167T>C	c.(3166-3168)aTt>aCt	p.I1056T		NM_005529.5	NP_005520.4	P98160	PGBM_HUMAN	heparan sulfate proteoglycan 2	1056	Laminin IV type A 2.	NA		NA	angiogenesis|cell adhesion|lipid metabolic process|lipoprotein metabolic process	basement membrane|extracellular space|plasma membrane	protein C-terminus binding			breast(6)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(15)|liver(1)|lung(44)|ovary(10)|pancreas(1)|prostate(10)|skin(9)|upper_aerodigestive_tract(3)|urinary_tract(3)	127		Colorectal(325;3.46e-05)|all_lung(284;7.93e-05)|Lung NSC(340;8.71e-05)|Renal(390;0.000219)|Breast(348;0.00222)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0498)|OV - Ovarian serous cystadenocarcinoma(117;1.14e-26)|Colorectal(126;4.18e-07)|COAD - Colon adenocarcinoma(152;1.82e-05)|GBM - Glioblastoma multiforme(114;3.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000756)|STAD - Stomach adenocarcinoma(196;0.00656)|KIRC - Kidney renal clear cell carcinoma(1967;0.00942)|READ - Rectum adenocarcinoma(331;0.0721)|Lung(427;0.223)	Becaplermin(DB00102)|Palifermin(DB00039)	GAAAGGCACAATGAAGGTGCT	0.637		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						46	49	48	NA		NA	NA	1		NA		NA									NA				22202372		2203	4300	6503	SO:0001583	missense			ENSG00000142798	HGNC:5273	NM_005529	Approved	uc001bfj.3	NA	Q16287|Q5SZI3|Q9H3V5	ENST00000374695.3	37	CCDS30625.1	.	.	.	.	.	.	.	.	.	.	G	2.104	-0.405408	0.04832	.	.	ENSG00000142798	ENST00000374695	T	0.33654	1.4	5.51	4.58	0.56647	Laminin B type IV (2);Laminin B, subgroup (1);	0.599141	0.13858	N	0.357873	T	0.10337	0.0253	N	0.00670	-1.27	0.23150	N	0.998215	B	0.02656	0.0	B	0.01281	0.0	T	0.27706	-1.0066	10	0.02654	T	1	.	9.6251	0.39746	0.1733:0.0:0.8267:0.0	.	1056	P98160	PGBM_HUMAN	T	1056	ENSP00000363827:I1056T	ENSP00000363827:I1056T	I	-	2	0	HSPG2	22074959	0.999000	0.42202	0.734000	0.30879	0.946000	0.59487	2.887000	0.48586	0.685000	0.31468	-0.215000	0.12644	ATT	HSPG2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000007598.1	109.7487	KEEP		-	111.764321	0.352381	37	68	---	---	---	---	1	0.9999999	2	56	0	94	40	74	0	94	2	TP
AMPD2	271	broad.mit.edu	37	1	110171834	110171834	+	Nonsense_Mutation	SNP	G	G	T			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr1:110171834G>T	ENST00000256578.3	+	13	2197	c.1837G>T	c.(1837-1839)Gaa>Taa	p.E613*	AMPD2_ENST00000342115.4_Nonsense_Mutation_p.E532*|AMPD2_ENST00000528667.1_Nonsense_Mutation_p.E613*|AMPD2_ENST00000528454.1_Nonsense_Mutation_p.E495*|RP5-1160K1.6_ENST00000369843.3_RNA|AMPD2_ENST00000526301.1_3'UTR|AMPD2_ENST00000393688.3_Nonsense_Mutation_p.E494*|AMPD2_ENST00000358729.4_Nonsense_Mutation_p.E538*	NM_004037.7	NP_004028.3	Q01433	AMPD2_HUMAN	adenosine monophosphate deaminase 2	613		NA		NA	purine base metabolic process|purine ribonucleoside monophosphate biosynthetic process|purine-containing compound salvage	cytosol	AMP deaminase activity|metal ion binding			breast(1)|large_intestine(3)|ovary(2)|skin(1)	7		all_epithelial(167;2.5e-05)|all_lung(203;0.000135)|Lung NSC(277;0.000269)|Breast(1374;0.244)		Lung(183;0.0425)|all cancers(265;0.0884)|Colorectal(144;0.109)|Epithelial(280;0.111)|LUSC - Lung squamous cell carcinoma(189;0.228)		CAGCCACCCGGAACTGCATCT	0.612		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						60	60	60	NA		NA	NA	1		NA		NA									NA				110171834		2203	4300	6503	SO:0001587	stop_gained			ENSG00000116337	HGNC:469		Approved	uc009wfh.2	NA	B4DZI5|Q14856|Q14857|Q16686|Q16687|Q16688|Q16729|Q5T693|Q5T695|Q96IA1|Q9UDX8|Q9UDX9|Q9UMU4	ENST00000256578.3	37	CCDS805.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	39|39	7.577397|7.577397	0.98368|0.98368	.|.	.|.	ENSG00000116337|ENSG00000116337	ENST00000342115;ENST00000528667;ENST00000256578;ENST00000358729;ENST00000528454;ENST00000393688|ENST00000369840	.|.	.|.	.|.	4.93|4.93	4.93|4.93	0.64822|0.64822	.|.	0.050350|.	0.85682|.	D|.	0.000000|.	.|T	.|0.67571	.|0.2907	.|.	.|.	.|.	0.80722|0.80722	A|A	1|1	.|.	.|.	.|.	.|.	.|.	.|.	.|T	.|0.66333	.|-0.5950	.|3	0.16896|.	T|.	0.51|.	-22.4731|-22.4731	17.931|17.931	0.88998|0.88998	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	.|.	.|.	.|.	X|V	532;613;613;538;495;494|583	.|.	ENSP00000256578:E613X|.	E|G	+|+	1|2	0|0	AMPD2|AMPD2	109973357|109973357	1.000000|1.000000	0.71417|0.71417	0.950000|0.950000	0.38849|0.38849	0.148000|0.148000	0.21650|0.21650	7.524000|7.524000	0.81866|0.81866	2.555000|2.555000	0.86185|0.86185	0.655000|0.655000	0.94253|0.94253	GAA|GGA	AMPD2-011	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000390615.1	31.790524	KEEP		+	35.924995	0.234375	15	49	---	---	---	---	1	0.9981757	6	39	0	77	15	56	0	77	2	TP
ZNF660	285349	broad.mit.edu	37	3	44635791	44635791	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr3:44635791G>C	ENST00000322734.2	+	3	439	c.106G>C	c.(106-108)Gac>Cac	p.D36H	RP11-944L7.4_ENST00000457331.1_RNA	NM_173658.2	NP_775929.2	Q6AZW8	ZN660_HUMAN	zinc finger protein 660	36		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			large_intestine(2)|lung(4)	6				KIRC - Kidney renal clear cell carcinoma(197;0.0468)|Kidney(197;0.0585)		TCAGTGCTGTGACCCTGCAAC	0.398		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						112	109	110	NA		NA	NA	3		NA		NA									NA				44635791		2203	4300	6503	SO:0001583	missense			ENSG00000144792	HGNC:26720	NM_173658	Approved	uc003cnl.1	NA	Q7Z331|Q8N9M8	ENST00000322734.2	37	CCDS2716.1	.	.	.	.	.	.	.	.	.	.	G	0.011	-1.697863	0.00725	.	.	ENSG00000144792	ENST00000416644;ENST00000322734	T	0.08282	3.11	4.65	0.874	0.19124	.	.	.	.	.	T	0.03608	0.0103	N	0.08118	0	0.09310	N	1	B	0.17268	0.021	B	0.15870	0.014	T	0.47262	-0.9131	8	.	.	.	.	5.2933	0.15739	0.3421:0.144:0.5138:0.0	.	36	Q6AZW8	ZN660_HUMAN	H	36	ENSP00000324605:D36H	.	D	+	1	0	ZNF660	44610795	0.000000	0.05858	0.000000	0.03702	0.008000	0.06430	0.498000	0.22530	0.295000	0.22570	0.655000	0.94253	GAC	ZNF660-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256756.4	82.340767	KEEP		+	85.272928	0.311828	29	64	---	---	---	---	1	0.3853475	2	2	0	106	33	71	0	106	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA						112	104	107	NA		NA	NA	7		NA		NA									NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	62.934869	KEEP		-	63.772234	0.372881	22	37	---	---	---	---	1	0.9980858	11	11	0	80	24	42	0	80	2	TP
EPHB6	0	broad.mit.edu	37	7	142562146	142562146	+	Silent	SNP	C	C	G			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr7:142562146C>G	ENST00000392957.2	+	7	1375	c.588C>G	c.(586-588)gtC>gtG	p.V196V	EPHB6_ENST00000442129.1_Silent_p.V196V|EPHB6_ENST00000411471.2_Intron	NM_004445.3	NP_004436.2	O15197	EPHB6_HUMAN	EPH receptor B6	196		NA		NA		extracellular region|integral to plasma membrane	ATP binding|ephrin receptor activity			NS(1)|breast(1)|central_nervous_system(4)|cervix(1)|endometrium(5)|kidney(4)|large_intestine(9)|lung(46)|ovary(2)|pancreas(2)|prostate(1)|skin(9)|stomach(1)|upper_aerodigestive_tract(1)	87	Melanoma(164;0.059)					AACTGAACGTCAAAGAGCGGA	0.657		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						132	145	140	NA		NA	NA	7		NA		NA									NA				142562146		2202	4299	6501	SO:0001819	synonymous_variant			ENSG00000106123	HGNC:3396		Approved	uc011kst.2	NA	A4D2I7|A8CDT5|D3DXD3|Q2TB23|Q2TB24	ENST00000392957.2	37	CCDS5873.2																																																																																			EPHB6-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000341329.1	326.23747	KEEP		+	334.279583	0.336283	114	225	---	---	---	---	1	1	52	50	0	428	138	268	0	428	2	TP
SECISBP2	79048	broad.mit.edu	37	9	91954833	91954833	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr9:91954833G>C	ENST00000375807.3	+	9	1338	c.1267G>C	c.(1267-1269)Gag>Cag	p.E423Q	SECISBP2_ENST00000339901.4_Missense_Mutation_p.E350Q|SECISBP2_ENST00000534113.2_Missense_Mutation_p.E355Q	NM_024077.3	NP_076982.3	Q96T21	SEBP2_HUMAN	SECIS binding protein 2	423		NA		NA	translation	nucleus	mRNA 3'-UTR binding			breast(1)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(7)|liver(2)|lung(11)|ovary(3)|skin(2)	32						AGACAGAATAGAGACACCGAA	0.403		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						100	100	100	NA		NA	NA	9		NA		NA									NA				91954833		2203	4300	6503	SO:0001583	missense			ENSG00000187742	HGNC:30972	NM_024077	Approved	uc004aqj.1	NA	Q5HYY1|Q8IYC0|Q9H0A1	ENST00000375807.3	37	CCDS6683.1	.	.	.	.	.	.	.	.	.	.	G	10.89	1.477821	0.26511	.	.	ENSG00000187742	ENST00000375807;ENST00000395669;ENST00000339901;ENST00000534113;ENST00000425851	T;T;T;T	0.72725	-0.68;-0.68;-0.68;0.93	4.94	2.99	0.34606	.	0.627907	0.15701	N	0.248906	T	0.48169	0.1485	N	0.17474	0.49	0.09310	N	1	B;B;B	0.23377	0.024;0.084;0.024	B;B;B	0.22601	0.013;0.04;0.007	T	0.24048	-1.0171	10	0.18276	T	0.48	-9.9042	5.5196	0.16925	0.0765:0.1412:0.6359:0.1463	.	430;350;423	Q59H19;Q96T21-2;Q96T21	.;.;SEBP2_HUMAN	Q	423;429;350;355;220	ENSP00000364965:E423Q;ENSP00000364959:E350Q;ENSP00000436650:E355Q;ENSP00000414288:E220Q	ENSP00000364959:E350Q	E	+	1	0	SECISBP2	91144653	0.394000	0.25246	0.867000	0.34043	0.987000	0.75469	1.923000	0.40055	1.295000	0.44724	0.655000	0.94253	GAG	SECISBP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052990.3	142.46835	KEEP		+	142.578057	0.463918	45	52	---	---	---	---	1	1	37	35	0	100	52	59	0	100	2	TP
GOT1	2805	broad.mit.edu	37	10	101180440	101180440	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr10:101180440G>A	ENST00000370508.5	-	2	268	c.241C>T	c.(241-243)Cgg>Tgg	p.R81W	GOT1_ENST00000471741.1_5'UTR|GOT1_ENST00000543866.1_Missense_Mutation_p.R60W	NM_002079.2	NP_002070.1	P17174	AATC_HUMAN	glutamic-oxaloacetic transaminase 1, soluble	81		NA		NA	aspartate catabolic process|cellular response to insulin stimulus|gluconeogenesis|response to glucocorticoid stimulus	cytosol	L-aspartate:2-oxoglutarate aminotransferase activity|pyridoxal phosphate binding			endometrium(2)|kidney(1)|large_intestine(6)|lung(5)|prostate(2)	16		Ovarian(717;0.028)|Colorectal(252;0.234)		Epithelial(162;4.76e-10)|all cancers(201;3.84e-08)	L-Aspartic Acid(DB00128)|L-Cysteine(DB00151)|L-Glutamic Acid(DB00142)|Pyridoxal Phosphate(DB00114)	GCACAGCTCCGGAACTCAGCC	0.488		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(173;770 3544 21601)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA						125	119	121	NA		NA	NA	10		NA		NA									NA				101180440		2203	4300	6503	SO:0001583	missense			ENSG00000120053	HGNC:4432	NM_002079	Approved	uc001kpr.3	NA	B2R6R7|Q5VW80	ENST00000370508.5	37	CCDS7479.1	.	.	.	.	.	.	.	.	.	.	G	18.10	3.549204	0.65311	.	.	ENSG00000120053	ENST00000370508;ENST00000543866	T;T	0.31510	1.49;1.49	5.77	5.77	0.91146	Aminotransferase, class I/classII (1);Pyridoxal phosphate-dependent transferase, major region, subdomain 1 (1);Pyridoxal phosphate-dependent transferase, major domain (1);	0.000000	0.85682	D	0.000000	T	0.61800	0.2376	M	0.84156	2.68	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.72338	0.977;0.977	T	0.64651	-0.6357	10	0.87932	D	0	-19.8922	19.9576	0.97228	0.0:0.0:1.0:0.0	.	81;81	Q2TU84;P17174	.;AATC_HUMAN	W	81;60	ENSP00000359539:R81W;ENSP00000445578:R60W	ENSP00000359539:R81W	R	-	1	2	GOT1	101170430	1.000000	0.71417	1.000000	0.80357	0.456000	0.32438	4.209000	0.58493	2.885000	0.99019	0.655000	0.94253	CGG	GOT1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049794.1	43.045221	KEEP		-	46.73223	0.253731	17	50	---	---	---	---	1	0.9999987	29	59	0	72	17	52	0	72	2	TP
Unknown	0	broad.mit.edu	37	12	9463773	9463773	+	IGR	SNP	G	G	A	rs111854872	by1000genomes	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr12:9463773G>A			NA	NA				SNORA75 (24355 upstream) : RP13-735L24.1 (56286 downstream)						NA		NA		NA							NA						TAACCTGTGCGGTGTGGTTTC	0.627		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA	NA		NA		NA									NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			-3.649972	KEEP			8.571502	0.064516	4	58	---	---	---	---	1	0.06978065	2	4	0	41	4	64	0	41	2	TP
ITPR2	3709	broad.mit.edu	37	12	26732960	26732960	+	Splice_Site	SNP	C	C	T			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr12:26732960C>T	ENST00000381340.3	-	33	4925	c.4509_splice	c.e33+1	p.Q1503_splice		NM_002223.2	NP_002214.2	Q14571	ITPR2_HUMAN	inositol 1,4,5-trisphosphate receptor, type 2	1503		NA		NA	activation of phospholipase C activity|energy reserve metabolic process|nerve growth factor receptor signaling pathway|platelet activation|regulation of insulin secretion|response to hypoxia	integral to membrane|plasma membrane enriched fraction|platelet dense tubular network membrane|sarcoplasmic reticulum membrane	calcium ion transmembrane transporter activity|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity		ETV6/ITPR2(2)	biliary_tract(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(2)|kidney(16)|large_intestine(20)|liver(1)|lung(51)|ovary(5)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(5)|urinary_tract(3)	125	Colorectal(261;0.0847)					TTTAACTTACCTGGAGGCTGG	0.368		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						97	88	91	NA		NA	NA	12		NA		NA									NA				26732960		1811	4070	5881	SO:0001630	splice_region_variant			ENSG00000123104	HGNC:6181	NM_002223	Approved	uc001rhg.3	NA	O94773	ENST00000381340.3	37	CCDS41764.1																																																																																			ITPR2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402732.1	63.810013	KEEP	Silent	-	65.890237	0.319444	23	49	---	---	---	---	1	0.9630648	5	9	0	50	27	55	0	50	2	TP
DDX23	9416	broad.mit.edu	37	12	49229995	49229995	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr12:49229995T>C	ENST00000308025.3	-	11	1370	c.1291A>G	c.(1291-1293)Atc>Gtc	p.I431V	DDX23_ENST00000553182.1_5'Flank	NM_004818.2	NP_004809.2	Q9BUQ8	DDX23_HUMAN	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23	431	Helicase ATP-binding.	NA		NA		catalytic step 2 spliceosome|nucleoplasm|U5 snRNP	ATP binding|ATP-dependent RNA helicase activity|nucleic acid binding|protein binding			NS(1)|cervix(1)|kidney(4)|large_intestine(6)|lung(17)|ovary(1)|prostate(1)|skin(2)|urinary_tract(3)	36						ACACCAATGATGTCACGATTC	0.507		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						197	182	187	NA		NA	NA	12		NA		NA									NA				49229995		2203	4300	6503	SO:0001583	missense				HGNC:17347	NM_004818	Approved	uc001rsm.3	NA	B2R600|O43188	ENST00000308025.3	37	CCDS8770.1	.	.	.	.	.	.	.	.	.	.	T	14.33	2.503802	0.44558	.	.	ENSG00000174243	ENST00000308025	T	0.10573	2.86	5.49	5.49	0.81192	DEAD-like helicase (2);DNA/RNA helicase, DEAD/DEAH box type, N-terminal (1);	0.000000	0.85682	D	0.000000	T	0.07683	0.0193	N	0.10837	0.055	0.80722	D	1	P	0.35700	0.516	B	0.39771	0.309	T	0.48246	-0.9052	10	0.15952	T	0.53	-11.6761	14.5545	0.68091	0.0:0.0:0.0:1.0	.	431	Q9BUQ8	DDX23_HUMAN	V	431	ENSP00000310723:I431V	ENSP00000310723:I431V	I	-	1	0	DDX23	47516262	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	7.909000	0.87444	2.079000	0.62486	0.459000	0.35465	ATC	DDX23-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000408897.2	128.89198	KEEP		-	134.460579	0.304878	50	114	---	---	---	---	1	1	50	86	0	177	52	124	0	177	2	TP
COPE	11316	broad.mit.edu	37	19	19030194	19030194	+	5'UTR	SNP	C	C	T			THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-EL-A4K9-Tumor-SM-3UTE6	THCA-TCGA-EL-A4K9-Normal-SM-3UTG3	g.chr19:19030194C>T	ENST00000262812.4	-	0	12				COPE_ENST00000600932.1_5'Flank|DDX49_ENST00000438170.2_5'Flank|COPE_ENST00000349893.4_5'Flank|COPE_ENST00000351079.4_5'Flank|DDX49_ENST00000247003.4_5'Flank|AC002985.3_ENST00000596918.1_Intron	NM_007263.3	NP_009194.2	O14579	COPE_HUMAN	coatomer protein complex, subunit epsilon	NA		NA		NA	COPI coating of Golgi vesicle|intra-Golgi vesicle-mediated transport|protein transport|retrograde vesicle-mediated transport, Golgi to ER	COPI vesicle coat|cytosol	binding|structural molecule activity			breast(1)|central_nervous_system(2)|kidney(2)|large_intestine(2)|lung(2)|ovary(1)|skin(1)	11						TCCTGAAAGACACGTCAGCCG	0.597		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA						30	33	32	NA		NA	NA	19		NA		NA									NA				19030194		2203	4297	6500	SO:0001623	5_prime_UTR_variant				HGNC:2234	NM_007263	Approved	uc002nkk.3	NA	O76097|Q6IBB8	ENST00000262812.4	37	CCDS12387.1																																																																																			COPE-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000464801.1	42.649511	KEEP		-	45.025181	0.288136	17	42	---	---	---	---	1	0.588262	2	5	0	108	18	51	0	108	2	TP
